Rybelsus (semaglutide) is an oral medication used to control blood sugar levels in adults with type 2 diabetes. Although clinical trials have shown that it is effective in promoting weight loss, the FDA has not yet formally approved it as a weight loss drug. Rybelsus, taken once daily, is typically incorporated as part of a regimen that includes diet and exercise.